References
1.
Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister e.V.: Krebs in Deutschland 2007/2008. Häufigkeiten und Trends, ed 8. Berlin, 2012.
2.
Schrodi S, Braisch U, Schenkkirsch G, Maisel T, Petsch S, Hölzel D, Klinkhammer-Schalke M, Mäder U, Schuller L, Heywang-Köbrunner SH, Meyer M, Engel J: Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008. Senologie 2013;10:225-235.
3.
Alexander FE, Anderson TJ, Brown HK, et al.: 14 years of follow-up from the Edinburgh randomized trial of breast cancer screening. Lancet 1999;353:1903-1908.
[PubMed]
4.
Anderson WF, Jatoi I, Devesa SS: Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut. Breast Cancer Res Treat 2006;99:333-340.
[PubMed]
5.
Duffy SW, Tabar L, Olsen AH, et al.: Absolute numbers of lives saved and overdiagnosis in breast cancer screening programme in England. J Med Screen 2010;17:25-30.
[PubMed]
6.
Olsen AH, Njor SH, Vejborg I, et al.: Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005;330:220.
[PubMed]
7.
Kerlikowske K: Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997;22:79-86.
[PubMed]
8.
Gøtzsche PC, Jørgensen KJ: Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877.
[PubMed]
9.
Welch H, Passow HJ: Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448-454.
[PubMed]
10.
Bleuler E: Das autistisch-undisziplinierte Denken in der Medizin und seine Überwindung, ed 5. Berlin, Heidelberg, New York, Springer, 1962.
11.
Porzsolt F, Williams AR, Kaplan RM (eds): Klinische Ökonomik. Effektivität und Effizienz von Gesundheitsleistungen. Landsberg, Ecomed, 2003.
12.
Porzsolt F, Kaplan RM (eds): Optimizing Health - Improving the Value of Healthcare Delivery. New York, Springer, 2006, pp 1-313.
13.
Porzsolt F (ed): Grundlagen der Klinischen Ökonomik. Schriftenreihe PVS-Verband Band 11, ed 1. Berlin, PVS-Verband, 2011, pp 1-270.
14.
Porzsolt F, Wirth A, Mayer-Steinacker R, Suhr P, Warszawski N, Schulte M, Negri G, Kleeberger L, Link KH, Betz E, Sarkar MR, Röttinger E: Quality assurance in oncology: definition of treatment goal and assessment of its achievement. Onkologie 1994; 17:454-457.
15.
Stengel D, Sehouli J, Porzsolt F: Are the results of randomized trials influenced by preference effects? Part I. Findings from a systematic review; in Porzsolt F, Kaplan RM (eds): Optimizing Health - Improving the Value of Healthcare Delivery. New York, Springer, 2006, pp 265-291.
16.
Porzsolt F, Stengel D: Are the results of randomized trials influenced by preference effects? Part II. Why current studies often fail to answer this question; in Porzsolt F, Kaplan RM (eds): Optimizing Health - Improving the Value of Healthcare Delivery. New York, Springer, 2006, pp 292-297.
17.
Jüni P, Altman DG, Egger M: Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
[PubMed]
18.
Metge CJ: What comes after producing the evidence? The importance of external validity to translating science to practice. Clin Ther 2011;33:578-580.
[PubMed]
19.
Tsuji I, Nishino Y, Hisamichi S: Healthy screenee bias in evaluating the effectiveness of cancer screening. Gan No Rinsho 1999;45:1301-1306.
20.
Du Prel J-B, Muttray A: Validität von Diagnostik-und Screening-Studien; in Porzsolt F (ed): Grundlagen der Klinischen Ökonomik. Schriftenreihe PVS-Verband Band 11, ed 1. Berlin, PVS-Verband, 2011, pp 56-57.
21.
Bleyer A, Welch HG: Effect of three decades of screening mammography on breast cancer incidence. N Engl J Med 2012;367:1998-2005.
[PubMed]
22.
Wegwarth O, Gigerenzer G: ‘There is nothing to worry about': gynaecologists' counseling on mammography. Patient Educ Couns 2011;84:251-256.
[PubMed]
23.
Goetzsche P, Jørgensen KJ, Zahl PH, Mæhlen J: Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 2012;23:15-21.
[PubMed]
24.
Letters: Women need better information on routine mammography. BMJ 2003;327:868-869.
[PubMed]
25.
Porzsolt F, Braubach P, Flurschütz PI, Göller A, Sailer MB, Weiss M, Wyer P: Medical students help avoid the expert bias in medicine. Creative Education 2012;3:1115-1121.
26.
Porzsolt F, Eisemann M, Habs M, Wyer P: Form follows function: pragmatic controlled trials (PCTs) have to answer different questions and require different designs than randomized controlled trials (RCTs). J Publ Health 2013;21:307-313.
[PubMed]
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.
